Zuzanna Brzosko

Bestie, here’s what’s good with Zuzanna Brzosko. This girl’s the real deal in biotech and startups. She’s a W18 batch alum of YC, which is already a badge of honor, but what she’s done before that? Holy shit. She’s got a solid background from Oxford and Cambridge, where she did her PhD and postdoc in neuroscience and physiology. Basically, she’s a brainiac who jumped into the biotech scene and crushed it.

She started out working at Goldman Sachs in biotech equity research, so she really understands how the money flows in pharma and biotech. But she didn’t stop there. She’s been involved with some big names like Eli Lilly now, where she’s a Senior Director in Corporate Strategy & External Innovation, basically, she’s shaping the future of oncology and life sciences from the inside. Before that, she was the head of biz dev at a biotech startup called Integrated Biosciences.

But the coolest part? She co-founded Sixfold Bioscience, a preclinical biotech company focused on drug delivery tech for gene therapies. She met her co-founders at Cambridge, where she was a postdoc and also president of Cambridge University Entrepreneurs, so she’s always been about startups and innovation. And guess what? She managed to get Y Combinator’s investment, which is no joke. That funding helped them build labs and grow the team fast. They raised a hefty seed round, like, £7.8 million, which is crazy for a biotech startup at that stage.

What’s wild is how she’s always been about pushing boundaries. From academia to Goldman Sachs to startups and now big pharma, her whole process screams one thing: she’s dead set on making a real impact in healthcare. Making money? That’s just the surface. The real drive is solving big problems, especially in neuroscience and cancer.

And beyond the biz, she’s out there mentoring and speaking about biotech and innovation. That means she’s not just in it for herself, she genuinely wants to lift others up and push the whole industry forward.

So, bottom line? Zuzanna Brzosko is this insane mix of academic genius, startup hustler, and corporate strategist. She’s built and scaled biotech companies, helped secure millions in funding, and now she’s shaping the future of medicine from the big pharma side. She’s the kind of person who sees a huge problem, jumps in, and just makes it happen. No Cap.